Readers Write: Healthcare’s Quietest Financial Problem

Healthcare’s Quietest Financial Problem
By Reed Liggin

Reed Liggin, RPh, MBA is co-founder and CEO of SlicedHealth.

Payer contracts are negotiated with extraordinary care. They often involve detailed financial modeling, language review, and extended debate among finance and managed care leaders who understand that the margin implications extend beyond the current fiscal year.

By the time an agreement is signed, the organization usually understands clearly what it expects to be paid and how those numbers fit into broader margin targets.

What is less clear, in many cases, is whether those expectations hold once the contract is operational. Negotiation is a focused event. Execution is an ongoing process that depends on claims configuration, payer adjudication logic, and a long list of small decisions that rarely receive executive attention. The contract may be sound, yet its performance in practice can drift in ways that are difficult to detect without deliberate review.

That is where healthcare’s quietest financial problem tends to live.

Most reimbursement misalignment is not dramatic. It does not look like a denial spike or a system outage. It looks like an almost-right payment, then another that is almost right, and then a few thousand more that are almost right. Those are the hardest errors to spot because they do not feel like errors.

The reason is simple: the contract is rarely a single rate. The contract is a set of conditions.

A surgical case might be paid under a base methodology, while the implant follows a different rule. A drug might be carved out if the NDC is present and paid under a different schedule if it is not. An outlier threshold might apply only after a cost calculation that depends on how charges were mapped and which revenue codes were recognized. A quality adjustment might be effective on paper in January, effective in the payer’s configuration in March, and not visible on the remittance in a way that makes it easy to reconcile.

Because the discrepancies are usually small, they tend to be absorbed into ordinary variance explanations. Margins fluctuate for many reasons. When reimbursement is directionally correct, it is easy to conclude that the contract is performing as intended. The temptation is to move on, because there is always something louder competing for attention. Over time, however, small differences across high-volume services can accumulate in ways that are more consequential than any single remittance would suggest.

The structure of most organizations reinforces this pattern. Contract negotiation is concentrated within managed care and finance leadership. Payment posting and denial management sit within revenue cycle. Financial performance is reviewed at an aggregate level.

Each function operates responsibly within its own scope. The precise alignment between negotiated language and adjudicated payment exists somewhere between those scopes, which makes it harder to see and harder to measure consistently.

Sampling can confirm that the world is not on fire, but does not reliably detect systematic drift across a high-volume population, especially when the drift is small and distributed across service lines, modifiers, and carve-outs. Those issues do not typically surface through a single appeal or an isolated audit finding. They reveal themselves gradually, if at all.

A practical constraint is that appeal timelines move quickly. Reconstructing the intent of a negotiated provision after months of operational activity is not simple. By the time a pattern becomes visible, the administrative effort required to pursue it may outweigh the perceived benefit, especially when the variance per claim appears modest. The economics of attention often favor larger, louder problems.

Healthcare finance is disciplined in many ways. Budgets are scrutinized. Forecasts are refined. Variance explanations are debated. But reimbursement accuracy, when it is mostly right, rarely commands the same intensity.

The difficulty is that reimbursement is foundational. When performance is directionally aligned but not exact, the difference can remain invisible inside aggregate results.

None of this implies widespread failure. It reflects the increasing complexity of reimbursement and the reality that operational systems interpret legal language through their own logic. Small gaps are easier to tolerate than large ones, and quiet gaps are easier to overlook than noisy ones.

In an environment where margins are narrow and expectations are high, quiet misalignment has a way of persisting longer than anyone would prefer. It does not demand attention. It rarely introduces itself. It simply continues in the background, one remittance at a time.

The contract ends with signatures. Its performance unfolds slowly, in details that are easy to assume and harder to verify. That space between intention and execution is where healthcare’s quietest financial problem tends to reside.